Systemic splanchnic hemodynamic effects molsidomine rats carbon tetrachloride-induced cirrhosis Molsidomine long-acting vasodilator antianginal agent portohepatic venous pressure gradient patients alcoholic cirrhosis study effects linsidomine active metabolite molsidomine systemic splanchnic hemodynamics rats cirrhosis microsphere technique placebo-treated rats linsidomine-treated animals significant decrease portal venous pressure mean arterial pressure peripheral resistances portal venous inflow splanchnic arteriolar resistances protocol-lateral resistances Cardiac output hepatic arterial blood flow portal blood flow hepatic blood flow different groups animals Linsidomine-treated rats trend collateral blood flow controls difference significant linsidomine portal venous pressure portocollateral resistances blood flow effects beneficial patients cirrhosis portal hypertension 